Melissa Johnson
- Co-authors
- Christopher CalabreseDavid FinkelsteinTal TeitzJill M. LahtiJerold E. RehgMichael A. DyerRachel C. BrennanJan Sedlacik
- Topics
- Neuroblastoma Research and Treatments (4 papers)CAR-T cell therapy research (2 papers)Cancer, Hypoxia, and Metabolism (2 papers)
- Cited by
- NeurologyCancer ResearchGenetics
- Journals
- BloodPLoS ONECancer Research
- Partner nations
- United StatesCanadaArgentina
In The Last Decade
Melissa Johnson
9 papers receiving 203 citations
Peers
Comparison fields: 5 of 50
- Neurology 99
- Molecular Biology 84
- Cancer Research 71
- Oncology 52
- Genetics 30
Countries citing papers authored by Melissa Johnson
This map shows the geographic impact of Melissa Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Johnson more than expected).
Fields of papers citing papers by Melissa Johnson
This network shows the impact of papers produced by Melissa Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Johnson. The network helps show where Melissa Johnson may publish in the future.
Co-authorship network of co-authors of Melissa Johnson
This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Johnson. A scholar is included among the top collaborators of Melissa Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Johnson. Melissa Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 14 | |
| 5 | 26 | |
| 6 | 4 | |
| 7 | 15 | |
| 8 | 48 | |
| 9 | 70 | |
| 10 | 23 |
About Melissa Johnson
Melissa Johnson is a scholar working on Applied Microbiology and Biotechnology, Toxicology and Neurology, having authored 10 papers that have together received 204 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (4 papers), CAR-T cell therapy research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Neurology (99 citations), Cancer Research (71 citations) and Genetics (22 citations). Melissa Johnson has collaborated with scholars based in United States, Canada and Argentina. Frequent co-authors include Christopher Calabrese, David Finkelstein, Tal Teitz, Jill M. Lahti, Jerold E. Rehg, Michael A. Dyer, Rachel C. Brennan, Jan Sedlacik, Sara M. Federico and Claudia M. Hillenbrand. Their work appears in journals such as Blood, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.